MJN : Summary for Mead Johnson Nutrition Company - Yahoo Finance

U.S. Markets open in 8 hrs 40 mins

Mead Johnson Nutrition Company (MJN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
87.50+0.03 (+0.03%)
At close: 4:01PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close87.47
Bid0.00 x
Ask0.00 x
Day's Range87.40 - 87.63
52 Week Range69.25 - 94.40
Avg. Volume3,488,632
Market Cap16.05B
PE Ratio (TTM)29.97
Earnings DateN/A
Dividend & Yield1.65 (1.89%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com5 days ago

    [$$] Reckitt Bags a Mead Johnson on the Mend

    Dow Jones Global Indexes|Global Stock Markets In an otherwise lackluster period for consumer-goods businesses,Reckitt Benckiser Group’s proposed purchase of U.S. infant and baby-food maker Mead Johnson Nutrition looks timely. Britain-based Reckitt Benckiser (ticker:ticker::RB.UK), whose brands include Scholl and Air Wick, said it will pay $16.6 billion for Mead Johnson (MJN), boosting its exposure to Asian and U.S. consumer-health markets. The tie-up comes weeks after Mead, known for its Enfamil infant formula, reported fourth-quarter sales fell 7% from a year earlier.

  • Business Wire6 days ago

    INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Mead Johnson Nutrition Company And Encourages Shareholders To Contact The Firm For Additional Information

    The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Mead Johnson Nutrition Company relating to the proposed buyout of Mead Johnson by Reckitt Benckiser Group plc.

  • PR Newswire8 days ago

    WEISSLAW LLP: Mead Johnson Nutrition Company Acquisition May Not Be in the Best Interests of MJN Shareholders

    NEW YORK, Feb. 14, 2017 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Mead Johnson Nutrition Company (MJN) ("MJN" or the "Company") in connection with the proposed acquisition of the Company by Britain's Reckitt Benckiser Group Plc.("Reckitt Benckiser") for $17.9 billion, inclusive of debt. Under the terms of the agreement, the Company's shareholders will receive $90.00 in cash for each MJN share they own. WeissLaw is investigating whether MJN's Board acted to maximize shareholder value prior to entering into the agreement. Notably, at least one analyst set a target price of $95.00 per share, or $5.00 above the offer price. Additionally, the per-share consideration is also $4.40 lower than the Company's 52-week high of $94.40.